NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE asked Natco Pharma to explain a recent increase in trading volume of its shares across exchanges. The company replied that it has been regularly making all required disclosures under SEBI's Listing Regulations. It confirmed there is no unpublished price-sensitive information that should have been disclosed. The company stated that the volume movement is purely market-driven and not due to any undisclosed corporate event.
This is a routine regulatory clarification and not a negative signal. It suggests no hidden news is driving the stock's trading activity, which means volume changes are likely due to normal market sentiment or broader sector movements.